EMA Event - New targets for clinical research

EMA Event - New targets for clinical research The EMA will host an online event to discuss the new targets for clinical trials set by the European medicines regulatory network (EMRN)

These targets, developed by the European Commission, Heads of Medicines Agencies, and the EMA, focus on:

1. Attractiveness – Making the EU a top destination for clinical research
2. Speed – Accelerating patient access to new treatments
3. Impact – Maximising the benefits of clinical trials conducted in Europe

Speakers include:

• Ana Zanoletty, Head of Clinical Trials Transformation workstream, EMA
• Corinna Hartung, Policy Officer, DG SANTE, European Commission
• Marianne Lunzer, Assessor Clinical Trials, Austrian Agency for Health (AGES)

Date and time

Wednesday, 24 September 1pm Irish Standard Time.

Registering to attend

This event is relevant to clinical trial sponsors, researchers and industry professionals working in the area of clinical trials. Visit the EMA registration page.